Last reviewed · How we verify
Compound Nanying zhitong Ointment
Compound Nanying zhitong Ointment is a Small molecule drug developed by Jiangsu Kanion Pharmaceutical Co., Ltd. It is currently in Phase 2 development for Dermatological conditions.
Nanying zhitong ointment's mechanism is not publicly available.
Nanying zhitong ointment's mechanism is not publicly available. Used for Dermatological conditions.
At a glance
| Generic name | Compound Nanying zhitong Ointment |
|---|---|
| Sponsor | Jiangsu Kanion Pharmaceutical Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
Unfortunately, there is limited information available on the exact mechanism of action of Nanying zhitong ointment.
Approved indications
- Dermatological conditions
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Compound Nanying zhitong Ointment CI brief — competitive landscape report
- Compound Nanying zhitong Ointment updates RSS · CI watch RSS
- Jiangsu Kanion Pharmaceutical Co., Ltd portfolio CI